Intralipid Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Post Your Intralipid Experience:
Recent Intralipid Side Effect Reports
Intralipid Side Effects Report #5347410-6
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on May 21, 2007. Male patient was treated with Intralipid. After drug was administered, patient experienced the following side effects: apnoea, bradycardia, erythema, infusion site extravasation. Intralipid dosage: unknown.
Intralipid Side Effects Report #5363542-0
Intralipid side effect was reported by a Pharmacist from UNITED STATES on June 18, 2007. Male patient, 48 years of age, weighting 134.5 lb, was diagnosed with parenteral nutrition, small intestinal obstruction and was treated with Intralipid. After drug was administered, patient experienced the following side effects: cellulitis
, phlebitis, pyrexia, therapeutic product contamination, white blood cell count increased. Intralipid dosage: 250ML DAILY IV DRIP.
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on May 21, 2007. Male patient was treated with Intralipid. After drug was administered, patient experienced the following side effects: apnoea, bradycardia, erythema, infusion site extravasation. Intralipid dosage: unknown.
Intralipid Side Effects Report #5363542-0
Intralipid side effect was reported by a Pharmacist from UNITED STATES on June 18, 2007. Male patient, 48 years of age, weighting 134.5 lb, was diagnosed with parenteral nutrition, small intestinal obstruction and was treated with Intralipid. After drug was administered, patient experienced the following side effects: cellulitis
, phlebitis, pyrexia, therapeutic product contamination, white blood cell count increased. Intralipid dosage: 250ML DAILY IV DRIP. View More
View All Intralipid FDA Adverse ReportsIntralipid Side Effects
Go to the top of the page
Intralipid Questions
Ask Community about Intralipid:
No comments have been provided.
Ask Community about Intralipid:
What is Your Question? Ask Community:
Intralipid Adverse Effect Reports (FDA)
Consumer or non-health professional from reported Intralipid side effect on July 07, 2006. Male patient, 74 years of age, weighting 110.2 lb, was diagnosed with parenteral nutrition, antibiotic prophylaxis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure acute, gastrointestinal haemorrhage, malnutrition, thrombocytopenia. Intralipid dosage: 200 ML, 1 IN 1 D, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, CLINDAMYCIN, FULCALIQ, GRAMALIL, PARIET, RENIVACE, NORVASC. Patient died on 05/12/2006.
Intralipid Side Effects Report #5080509-0
Intralipid side effect was reported by a Consumer or non-health professional from on July 20, 2006. Male patient, 74 years of age, weighting 110.2 lb, was diagnosed with parenteral nutrition, antibiotic prophylaxis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure acute, gastrointestinal haemorrhage, thrombocytopenia. Intralipid dosage: 200 ML, 1 IN 1 D, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, CLINDAMYCIN, FULCALIQ, GRAMALIL, PARIET, RENIVACE, NORVASC. Patient died on 05/12/2006.
Intralipid Side Effects Report #5517735-X
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis, staphylococcal infection . Intralipid dosage: unknown.
Intralipid Side Effects Report #5517736-1
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: central line infection, device failure, staphylococcal infection. Intralipid dosage: unknown.
Intralipid Side Effects Report #5517740-3
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis neonatal, staphylococcal infection. Intralipid dosage: unknown.
Intralipid Side Effects Report #5517741-5
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related complication, central line infection, device breakage, staphylococcal infection. Intralipid dosage: unknown.
Intralipid Side Effects Report #5517742-7
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis, staphylococcal infection . Intralipid dosage: unknown.
Intralipid Side Effects Report #5517743-9
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood disorder, central line infection, infusion site extravasation, neonatal disorder, staphylococcal infection. Intralipid dosage: unknown.
Intralipid Side Effects Report #5603415-9
Consumer or non-health professional from reported Intralipid side effect on Dec 07, 2007. Male patient, weighting 2.43 lb, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: abdominal distension, bilirubin conjugated abnormal, blood bilirubin abnormal, failure to thrive, hepatic enzyme increased, incorrect dose administered, intraventricular haemorrhage, neonatal disorder. Intralipid dosage: unknown. During the same period patient was treated with PARENTERAL NUTRITION.
Intralipid Side Effects Report #5664425-9
Intralipid side effect was reported by a Consumer or non-health professional from on Feb 27, 2008. Female patient, 92 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: deep vein thrombosis. Intralipid dosage: 1200 ML. During the same period patient was treated with HICALIQ, NEOAMIYU, PARESAFE, HUMULIN R, ZYVOX. Patient died.
Intralipid Side Effects Report #5825134-6
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on July 11, 2008. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood glucose increased, inappropriate device programming, metabolic function test abnormal. Intralipid dosage: 840 ML, 1 IN 1 HR, INTRAVENOUS DRIP. During the same period patient was treated with PROTEIN, DEXTROSE, POTASSIUM, CALCIUM, MAGNESIUM, PHOSPHATE, TRACE ELEMENTS.
Intralipid Side Effects Report #6060359-9
Intralipid side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2009. Female patient, 80 years of age, weighting 112.0 lb, was treated with Intralipid. After drug was administered, patient experienced the following side effects: pancreatitis. Intralipid dosage: 500 ML Q 48H IV. During the same period patient was treated with CHOLESTYRAMINE, INSULIN, LOVENOX, FLAGYL, ATIVAN, VANCOMYCIN, FOSINOPRIL.
Intralipid Side Effects Report #4556528-7
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Female patient, child 2 years of age, weighting 28.66 lb, was diagnosed with volvulus of bowel and was treated with Intralipid. After drug was administered, patient experienced the following side effects: bacterial sepsis, fungal sepsis, hepatic failure, infusion site infection, pancreatitis. Intralipid dosage: 14 ML/ 1 DASILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TRAVASOL, VITAMIN C, HEPARIN, LEVOCARNITINE.
Intralipid Side Effects Report #4556542-1
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Female patient, child 4 years of age, weighting 36.38 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, disseminated intravascular coagulation, liver function test abnormal. Intralipid dosage: 200 ML/- DAILY/ INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TROPHAMINE, ZANTAC. Patient died on 08/29/2004.
Intralipid Side Effects Report #4556545-7
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, child 6 years of age, weighting 53.13 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemorrhage, liver function test abnormal, viral infection. Intralipid dosage: 220 ML/- DAILY / INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TRAVASOL, NORMAL SALINE, K ACETATE. Patient was hospitalized.
Intralipid Side Effects Report #4556550-0
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, weighting 13.23 lb, was diagnosed with congenital intestinal malformation and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood bilirubin unconjugated increased, liver function test abnormal. Intralipid dosage: 33 ML/ 1 DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC.
Intralipid Side Effects Report #4556560-3
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, weighting 10.93 lb, was diagnosed with gastroschisis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter sepsis, cholestasis, condition aggravated, pyrexia. Intralipid dosage: 24 ML/ - DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC, LEVOCARNITINE, HEPARIN, MULTVITAMINS. Patient was hospitalized.
Intralipid Side Effects Report #4556562-7
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, child 7 years of age, weighting 51.59 lb, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: cholestasis, colectomy, hepatic failure, liver transplant. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TRAVASOL, RINGER, ZANTAC.
Intralipid Side Effects Report #4556566-4
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, weighting 15.65 lb, was diagnosed with congenital megacolon and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia of chronic disease, bacterial infection, cholestasis. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE.
Intralipid Side Effects Report #4556568-8
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, child 10 years of age, weighting 76.06 lb, was diagnosed with gastroschisis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, haematochezia, intestinal obstruction, jaundice. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TRAVASOL, HEPARIN, LEVOCARNITINE. Patient was hospitalized.
Intralipid Side Effects Report #4599391-0
Pharmacist from reported Intralipid side effect on Mar 03, 2005. Female patient, 81 years of age, weighting 152.1 lb, was diagnosed with gastrointestinal disorder and was treated with Intralipid. After drug was administered, patient experienced the following side effects: liver function test abnormal. Intralipid dosage: 50 MLS/HOUR DAILY FOR 10 H OTHER.
Intralipid Side Effects Report #4655305-6
Intralipid side effect was reported by a Physician from on Dec 15, 2003. Female patient, 80 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock. Intralipid dosage: 250 MG/ -TOTAL/ INTRAVENOUS INF 20 MINUTES.
Intralipid Side Effects Report #4691477-5
Pharmacist from reported Intralipid side effect on Jan 22, 2004. Female patient, 37 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: hypersensitivity, swollen tongue, urticaria. Intralipid dosage: unknown.
Go to the top of the page
Intralipid Side Effects Report #5054110-9
Consumer or non-health professional from reported Intralipid side effect on July 07, 2006. Male patient, 74 years of age, weighting 110.2 lb, was diagnosed with parenteral nutrition, antibiotic prophylaxis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure acute, gastrointestinal haemorrhage, malnutrition, thrombocytopenia. Intralipid dosage: 200 ML, 1 IN 1 D, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, CLINDAMYCIN, FULCALIQ, GRAMALIL, PARIET, RENIVACE, NORVASC. Patient died on 05/12/2006.
Intralipid Side Effects Report #5080509-0
Intralipid side effect was reported by a Consumer or non-health professional from on July 20, 2006. Male patient, 74 years of age, weighting 110.2 lb, was diagnosed with parenteral nutrition, antibiotic prophylaxis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure acute, gastrointestinal haemorrhage, thrombocytopenia. Intralipid dosage: 200 ML, 1 IN 1 D, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, CLINDAMYCIN, FULCALIQ, GRAMALIL, PARIET, RENIVACE, NORVASC. Patient died on 05/12/2006.
Intralipid Side Effects Report #5517735-X
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis
, staphylococcal infection . Intralipid dosage: unknown. Intralipid Side Effects Report #5517736-1
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: central line infection, device failure, staphylococcal infection
. Intralipid dosage: unknown. Intralipid Side Effects Report #5517740-3
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis neonatal, staphylococcal infection
. Intralipid dosage: unknown. Intralipid Side Effects Report #5517741-5
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related complication, central line infection, device breakage, staphylococcal infection
. Intralipid dosage: unknown. Intralipid Side Effects Report #5517742-7
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, device failure, sepsis
, staphylococcal infection . Intralipid dosage: unknown. Intralipid Side Effects Report #5517743-9
Intralipid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood disorder, central line infection, infusion site extravasation, neonatal disorder, staphylococcal infection
. Intralipid dosage: unknown. Intralipid Side Effects Report #5603415-9
Consumer or non-health professional from reported Intralipid side effect on Dec 07, 2007. Male patient, weighting 2.43 lb, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: abdominal distension, bilirubin conjugated abnormal, blood bilirubin abnormal, failure to thrive, hepatic enzyme increased, incorrect dose administered, intraventricular haemorrhage, neonatal disorder. Intralipid dosage: unknown. During the same period patient was treated with PARENTERAL NUTRITION.
Intralipid Side Effects Report #5664425-9
Intralipid side effect was reported by a Consumer or non-health professional from on Feb 27, 2008. Female patient, 92 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: deep vein thrombosis
. Intralipid dosage: 1200 ML. During the same period patient was treated with HICALIQ, NEOAMIYU, PARESAFE, HUMULIN R, ZYVOX. Patient died.Intralipid Side Effects Report #5825134-6
Consumer or non-health professional from UNITED STATES reported Intralipid side effect on July 11, 2008. Female patient was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood glucose increased, inappropriate device programming, metabolic function test abnormal. Intralipid dosage: 840 ML, 1 IN 1 HR, INTRAVENOUS DRIP. During the same period patient was treated with PROTEIN, DEXTROSE, POTASSIUM, CALCIUM, MAGNESIUM, PHOSPHATE, TRACE ELEMENTS.
Intralipid Side Effects Report #6060359-9
Intralipid side effect was reported by a Pharmacist from UNITED STATES on Jan 29, 2009. Female patient, 80 years of age, weighting 112.0 lb, was treated with Intralipid. After drug was administered, patient experienced the following side effects: pancreatitis. Intralipid dosage: 500 ML Q 48H IV. During the same period patient was treated with CHOLESTYRAMINE, INSULIN, LOVENOX, FLAGYL, ATIVAN, VANCOMYCIN, FOSINOPRIL.
Intralipid Side Effects Report #4556528-7
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Female patient, child 2 years of age, weighting 28.66 lb, was diagnosed with volvulus of bowel and was treated with Intralipid. After drug was administered, patient experienced the following side effects: bacterial sepsis, fungal sepsis, hepatic failure, infusion site infection, pancreatitis. Intralipid dosage: 14 ML/ 1 DASILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TRAVASOL, VITAMIN C, HEPARIN, LEVOCARNITINE.
Intralipid Side Effects Report #4556542-1
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Female patient, child 4 years of age, weighting 36.38 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter related infection, disseminated intravascular coagulation, liver function test abnormal. Intralipid dosage: 200 ML/- DAILY/ INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TROPHAMINE, ZANTAC. Patient died on 08/29/2004.
Intralipid Side Effects Report #4556545-7
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, child 6 years of age, weighting 53.13 lb, was diagnosed with malabsorption and was treated with Intralipid. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemorrhage, liver function test abnormal, viral infection
. Intralipid dosage: 220 ML/- DAILY / INTRAVENOUS IN. During the same period patient was treated with DEXTROSE, TRAVASOL, NORMAL SALINE, K ACETATE. Patient was hospitalized. Intralipid Side Effects Report #4556550-0
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, weighting 13.23 lb, was diagnosed with congenital intestinal malformation and was treated with Intralipid. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood bilirubin unconjugated increased, liver function test abnormal. Intralipid dosage: 33 ML/ 1 DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC.
Intralipid Side Effects Report #4556560-3
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, weighting 10.93 lb, was diagnosed with gastroschisis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: catheter sepsis, cholestasis, condition aggravated, pyrexia. Intralipid dosage: 24 ML/ - DAILY/ INTRAVENOUS INF. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE, ZANTAC, LEVOCARNITINE, HEPARIN, MULTVITAMINS. Patient was hospitalized.
Intralipid Side Effects Report #4556562-7
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, child 7 years of age, weighting 51.59 lb, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: cholestasis, colectomy, hepatic failure, liver transplant
. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TRAVASOL, RINGER, ZANTAC. Intralipid Side Effects Report #4556566-4
Pharmacist from reported Intralipid side effect on Sept 17, 2004. Male patient, weighting 15.65 lb, was diagnosed with congenital megacolon and was treated with Intralipid. After drug was administered, patient experienced the following side effects: anaemia of chronic disease, bacterial infection
, cholestasis. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TROPHAMINE, CYSTEINE. Intralipid Side Effects Report #4556568-8
Intralipid side effect was reported by a Pharmacist from on Sept 17, 2004. Male patient, child 10 years of age, weighting 76.06 lb, was diagnosed with gastroschisis and was treated with Intralipid. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, haematochezia, intestinal obstruction, jaundice
. Intralipid dosage: unknown. During the same period patient was treated with DEXTROSE, TRAVASOL, HEPARIN, LEVOCARNITINE. Patient was hospitalized. Intralipid Side Effects Report #4599391-0
Pharmacist from reported Intralipid side effect on Mar 03, 2005. Female patient, 81 years of age, weighting 152.1 lb, was diagnosed with gastrointestinal disorder and was treated with Intralipid. After drug was administered, patient experienced the following side effects: liver function test abnormal. Intralipid dosage: 50 MLS/HOUR DAILY FOR 10 H OTHER.
Intralipid Side Effects Report #4655305-6
Intralipid side effect was reported by a Physician from on Dec 15, 2003. Female patient, 80 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock. Intralipid dosage: 250 MG/ -TOTAL/ INTRAVENOUS INF 20 MINUTES.
Intralipid Side Effects Report #4691477-5
Pharmacist from reported Intralipid side effect on Jan 22, 2004. Female patient, 37 years of age, was diagnosed with parenteral nutrition and was treated with Intralipid. After drug was administered, patient experienced the following side effects: hypersensitivity, swollen tongue, urticaria. Intralipid dosage: unknown.
0%